Advisory Board February 2, 2024

The Biden administration on Thursday sent pharmaceutical companies initial offers for 10 drugs that will be part of Medicare’s new drug price negotiation program under the Inflation Reduction Act (IRA). However, the program is the subject of several ongoing lawsuits filed by drug manufacturers that have argued the law is unconstitutional.

Background

The IRA, which was signed into law in August 2022, includes several drug pricing provisions. Under the law, Medicare will be able to negotiate certain prescription drug prices with pharmaceutical companies. This provision will initially apply...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Medicare Coverage Of Medical Technologies In A New Era
An Argument For A New Medicare Prospective Payment System Methodology For Certified Community Behavioral Health Clinics
What's going on with physician pay?
Ep. 54: Medicare cuts and physician challenges with Norman K. "Kip" Beals III, MD
Home Improvements Can Help People Age Independently. But Medicare Seldom Picks Up the Bill.

Share This Article